You will be given a definition of a task first, then an example. Follow the example to solve a new instance of the task.
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Why? This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

New input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Infection Reduction Labeling Act of
2014''.

SEC. 2. TREATMENT OF SOLID ANTIMICROBIAL COPPER ALLOYS UNDER FEDERAL
INSECTICIDE, FUNGICIDE, AND RODENTICIDE ACT.

Section 3 of the Federal Insecticide, Fungicide, and Rodenticide
Act (7 U.S.C. 136a) is amended by adding at the end the following new
subsection:
''(i) Claims Made for Solid Antimicrobial Copper Alloys.--
''(1) Certain claims authorized.--Notwithstanding any other
provision of this Act, solid antimicrobial copper alloys, and
products made from such alloys, may be marketed, distributed,
or sold with labeling making claims regarding the microbial
reduction or infection control efficacy of the alloys if the
claims are consistent with the results of--
''(A) federally-funded clinical trials finding
greater than 25 percent reductions in infection rate or
50 percent reductions in microbial burden; or
''(B) federally-funded clinical trials finding
statistically significant reductions in infection rate
or microbial burden.
''(2) Submission or review of efficacy data waived.--The
registration of solid antimicrobial copper alloys under this
section shall not require submission or review of efficacy data
related to claims consistent with the results of the clinical
trials described in paragraph (1).
''(3) Consistency of claims with agency-registered product
label.--
''(A) In general.--Claims described in paragraph
(1) shall be consistent with the product label
registered under this section.
''(B) Process for modification of labeling.--In
lieu of the notification process under subsection
(c)(9), registration of a solid antimicrobial copper
alloy may be modified to ensure the consistency of
claims described in paragraph (1) with the product
labeling pursuant to the following process:
''(i) The registrant shall submit a
notification identifying the proposed claims
that are consistent with the results of the
clinical trials described in paragraph (1), and
include a copy of the proposed amended product
label.
''(ii) Within 30 days after receipt of such
a notification, the Administrator shall--
''(I) notify the registrant in
writing if the Administrator objects to
any of the proposed claims as not
consistent with the results of the
clinical trials described in paragraph
(1); and
''(II) state the reasons why.
''(iii) A registrant may file a response to
any such objection not later than 30 days after
the registrant's receipt of the objection.
''(iv) After receipt and consideration of
any such response, the Administrator shall
issue a decision within 30 days.
''(v) A decision under clause (iv) shall be
considered to be a final agency action.
''(vi) A registrant may distribute or sell
a solid antimicrobial copper alloy product with
the claims described in paragraph (1) after 60
days of submission of the notification
described in this subparagraph, unless the
Administrator issues an objection as described
in this subparagraph.
''(4) Definition.--In this subsection, the term 'solid
antimicrobial copper alloy' means a solid copper alloy that--
''(A) is registered under this section;
''(B) is listed under Environmental Protection
Agency registration number 82012-1, 82012-2, 82012-3,
82012-4, 82012-5, or 82012-6, or is otherwise
identified by a Unified Numbering System code in an
Environmental Protection Agency registration;
''(C) has a copper content of not less than 60
weight percent; and
''(D) has a content of not more than 0.1 weight
percent of each of the following: lead, chromium, and
arsenic.''.

SEC. 3. TREATMENT OF SOLID ANTIMICROBIAL COPPER ALLOYS UNDER FEDERAL
FOOD, DRUG, AND COSMETIC ACT.

Subchapter E of chapter V of the Federal Food, Drug, and Cosmetic
Act is amended by inserting after section 569C of such Act (21 U.S.C.
360bbb-8c) the following:

''SEC. 569D. SOLID ANTIMICROBIAL COPPER ALLOYS.

''(a) Exclusion From Treatment as Drug or Device.--A product that
is made from solid antimicrobial copper alloy and has labeling making a
claim regarding the microbial reduction or infection control efficacy
of the alloy, consistent with the results of federally-funded clinical
trials, shall not, by virtue of such claim--
''(1) be treated as a drug or device, or as a combination
thereof, for purposes of this Act; or
''(2) otherwise be subject to regulation by the Food and
Drug Administration.
''(b) Definition.--In this section, the term 'solid antimicrobial
copper alloy' means a solid copper alloy that--
''(1) is listed under Environmental Protection Agency
registration number 82012-1, 82012-2, 82012-3, 82012-4, 82012-
5, or 82012-6, or is otherwise identified by a Unified
Numbering System code in an Environmental Protection Agency
registration;
''(2) has a copper content of not less than 60 weight
percent; and
''(3) has a content of not more than 0.1 weight percent of
each of the following: lead, chromium, and arsenic.''.
Solution:
Infection Reduction Labeling Act of 2014 - Amends the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to authorize solid antimicrobial copper alloys, and products made from such alloys, to be marketed, distributed, or sold with labels about their infection reduction and control efficacy if the antimicrobial claims made on the label are consistent with the results of federally-funded clinical trials finding: (1) greater than 25% reductions in infection rate or 50% reductions in microbial burden, or (2) statistically significant reductions in infection rate or microbial burden. Waives alloys from requirements to submit or review efficacy data related to the antimicrobial claims if the claims are consistent with the results of the trials. Sets forth an alternative process to modify the labeling of an alloy. Amends the Federal Food, Drug, and Cosmetic Act to exclude a product that is made from the alloy and has the antimicrobial labeling from regulation and treatment as a drug or device .